These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 2039678
1. Comparative effects of the diastereoisomers, quinine and quinidine in producing phenocopy debrisoquine poor metabolisers (PMs) in healthy volunteers. Ayesh R, Dawling S, Hayler A, Oates NS, Cholerton S, Widdop B, Idle JR, Smith RL. Chirality; 1991; 3(1):14-8. PubMed ID: 2039678 [Abstract] [Full Text] [Related]
9. Quinidine but not quinine inhibits in man the oxidative metabolic routes of methoxyphenamine which involve debrisoquine 4-hydroxylase. Muralidharan G, Hawes EM, McKay G, Korchinski ED, Midha KK. Eur J Clin Pharmacol; 1991; 41(5):471-4. PubMed ID: 1761076 [Abstract] [Full Text] [Related]
10. Quinidine inhibition of debrisoquine S(+)-4- and 7-hydroxylations in Chinese of different CYP2D6 genotypes. Bertilsson L, Meese CO, Yue QY, Dahl ML, Ingelman-Sundberg M, Johansson I, Säwe J, Eichelbaum M. Pharmacogenetics; 1993 Apr; 3(2):94-100. PubMed ID: 8100167 [Abstract] [Full Text] [Related]
15. Influence of rifampicin, phenobarbital and cimetidine on mixed function monooxygenase in extensive and poor metabolizers of debrisoquine. Leclercq V, Desager JP, Horsmans Y, Van Nieuwenhuyze Y, Harvengt C. Int J Clin Pharmacol Ther Toxicol; 1989 Dec; 27(12):593-8. PubMed ID: 2613393 [Abstract] [Full Text] [Related]
18. Polymorphic drug oxidation in humans. Eichelbaum M. Fed Proc; 1984 May 15; 43(8):2298-302. PubMed ID: 6714436 [Abstract] [Full Text] [Related]
19. Inhibition of debrisoquine hydroxylation with quinidine in subjects with three or more functional CYP2D6 genes. Dalén P, Dahl M, Andersson K, Bertilsson L. Br J Clin Pharmacol; 2000 Feb 15; 49(2):180-4. PubMed ID: 10671914 [Abstract] [Full Text] [Related]